Publications
11
Citations
143
Est. group size
—
Recurring co-author estimate
Active years
18
Publishing since 2008
Kenneth Mackie's research focuses on cannabinoids—compounds related to cannabis and the body's own signaling molecules that act on similar receptors—and how they affect the nervous system and other physiological processes. His work spans neuropharmacology (how drugs act on the brain and nerves), metabolism, and cell biology, including how immune cells clear dying cells. Recent work explores small molecules that influence enzymes involved in producing these signaling lipids.
Based on the provided data, recorded publication activity is low, with only single publications appearing in the most recent years (2023–2025).
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Small Molecule Activation of NAPE-PLD Enhances Efferocytosis by Macrophages
bioRxiv (Cold Spring Harbor Laboratory) · 2023
- bioRxiv (Cold Spring Harbor Laboratory)×1
- Frontiers in Microbiomes×1
- Bioinformatics×1
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile